CBD Biotech Inc., a pharmaceutical company incorporated in the Cayman Islands, announced the launch of six new products, in reference to its long-term deliberated plans of expanding its Hemp/CBD skincare product line.
CBD Biotech is a fully owned subsidiary of a California based Capital Market Company, ChineseInvestors.com Inc. that specializes in patented and platform time-release technologies to enhance the Cannabinoid delivery and efficacy in users. Founded in 1999, the prime focus of ChineseInvestors.com is on the investment in distribution and R&D of Hemp-based CBD products. It also offers a proprietary commercial news agency and content platform providing information to the global Chinese-speaking community, in China, the US, Canada and around the world.
The new skincare products of CBD Biotech Inc. are as follows:
- CBD Oligopeptides Repair Eye Cream
- CBD Nerve Acylamide Eye Essence
- CBD Hemp Eye Mask
- CBD Gold Nicotinamide Essence
- CBD Handmade Horse Oil Soap
- CBD Clear Bright
CBD Biotech is the pioneer of the CBD-infused skincare industry in China. With the release of these new skincare products, CBD Biotech aims to elevate its brand awareness, gain customer loyalty and emerge as one of the leading Chinese CBD public trading company.
While use of Cannabis is still illegal in China, hemp-based CBD, which discreetly is not under controlled substance, can be legally included in skincare products, thus opening a potential market of nearly two billion people for the Company.